Skip to main content

Advertisement

SpringerLink
Log in

Progress and emerging challenges in preventing mother-to-child transmission

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

There is a widening gulf between the effectiveness of interventions for preventing mother-to-child transmission (PMTCT) of HIV in sub-Saharan Africa and other regions of the world. Compared with long-course, triple antiretroviral regimens used in Brazil, Europe, and the United States, most countries in sub-Saharan Africa use a less effective regimen consisting of single-dose nevirapine (NVP). Furthermore, the documentation of unacceptable levels of resistance following this regimen makes it prudent to review current PMTCT strategies. Not only is it necessary to review the use of single-dose NVP for PMTCT, but efforts to minimize breast milk transmission of HIV should be enhanced. This review summarizes the programmatic and evidence-based reasons for adopting a standardized approach to long-course, triple-drug MTCT prophylaxis in sub-Saharan Africa. Antiretroviral treatment programs in resource-constrained settings have achieved similar levels of effectiveness as high-income countries, despite adopting standardized approaches to antiretroviral treatment. Similarly, in resource-constrained settings with adequate infrastructure and programmatic capacity, use of standardized, long-course, triple-drug regimens for MTCT prevention are likely to achieve levels of effectiveness seen in Brazil, Europe, and the United States.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Joint United Nations Program on HIV/AIDS, World Health Organization: AIDS Epidemic Update 2004.Geneva, Switzerland: World Health Organization; 2004.

    Google Scholar 

  2. Newell ML, Brahmbhatt H, Ghys PD: Child mortality and HIV infection in Africa: a review. AIDS 2004, 18(Suppl 2):S27–34.

    Article  PubMed  Google Scholar 

  3. United States Agency for International Development, Joint United Nations Program on HIV/AIDS, World Health Organization, the POLICY Project:Coverage of selected services for HIV/ AIDS prevention, care and support in low and middle income countries in 2003. Washington, DC:the POLICY Project; 2004.

    Google Scholar 

  4. Thorne C, Newell ML: European Collaborative Study: Are girls more at risk of intrauterine-acquired HIV infection than boys? AIDS 2004, 18:344–347.

    Article  PubMed  Google Scholar 

  5. Dorenbaum A, Cunningham CK, Gelber RD, et al.: Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA 2002, 288:189–198.

    Article  PubMed  CAS  Google Scholar 

  6. Cooper ER, Charurat M, Mofenson L, et al.: Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002, 29:484–494.

    PubMed  CAS  Google Scholar 

  7. Joint United Nations Program on HIV/AIDS, World Health Organization:Consultation on STD interventions for preventing HIV: what is the evidence?Geneva, Switzerland: World Health Organization; 2000.

    Google Scholar 

  8. Connor EM, Sperling RS, Gelber R, et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994, 331:1173–1180.

    Article  PubMed  CAS  Google Scholar 

  9. Coll O, Fiore S, Floridia M, et al.: Pregnancy and HIV infection: A European consensus on management. AIDS 2002, 16(Suppl 2):S1–18.

    PubMed  Google Scholar 

  10. British HIV association: Guidelines for management of HIV infection in pregnant women and the prevention of mother-to-child transmission. London, United Kingdom: British HIV association; 2001.

    Google Scholar 

  11. Ministèrio da Saudè Recomendações para Profilaxia da Transmissão Vertical do HIV e Terapia Anti-retroviral em Gestantes. Brazil: Ministèrio da Saudè; 2003.

    Google Scholar 

  12. United States Public Health Service Task Force: Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Rockville, MD: United States Department of Health and Human Services; 2004.

    Google Scholar 

  13. World Health Organization: Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings. Geneva, Switzerland: World Health Organization; 2004. These are guidelines that have been developed for the management of HIV-infected pregnant women and provide a choice of options that are available in resource-poor settings.

    Google Scholar 

  14. CoovadiaH: Antiretroviral agents—how best to protect infants from HIV and save their mothers from AIDS. N Engl J Med 2004, 351:289–292.

    Article  PubMed  CAS  Google Scholar 

  15. Shapiro D, Tuolala R, Pollack H, Burchett S: Mother-to-child HIV transmission risk according to antiretroviral therapy, mode of delivery, and viral load in 2895 U.S. women (PACTG 367) [abstract]. Paper presented at11th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, February 8–11, 2004.

  16. United States Public Health Service Task Force: Recommendations for use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Rockville, MD: United States Department of Health and Human Services; 1998.

    Google Scholar 

  17. United States Public Health Service Task Force:Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Rockville, MD:United States Department of Health and Human Services; 2001.

    Google Scholar 

  18. The European Collaborative Study and the Swiss Mother and Child HIV Cohort Study: Combination antiretroviral therapy and duration of pregnancy. AIDS 2000, 14:2913–2920.

    Article  Google Scholar 

  19. Timmermans S, Tempelman C, Godfried MH, et al.: Nelfinavir and nevirapine side effects during pregnancy. AIDS 2005, 19:795–799.

    Article  PubMed  CAS  Google Scholar 

  20. Lallemant M, Jourdain G, Le Coeur S, et al.: Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004, 351:217–228.

    Article  PubMed  Google Scholar 

  21. Jourdain G, Ngo-Giang-Huong N, Le Coeur S, et al.: Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med 2004, 351:229–240.

    Article  PubMed  CAS  Google Scholar 

  22. Chene G, Sterne JA, May M, et al.: Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet 2003, 362:679–686.

    Article  PubMed  CAS  Google Scholar 

  23. Nolan M, Fowler MG, Mofenson LM: Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance. J Acquir Immune Defic Syndr 2002, 30:216–229.

    PubMed  CAS  Google Scholar 

  24. Johnson JA, Li JF, Morris L, et al.: Emergence of Drug-Resistant HIV-1 after Intrapartum Administration of Single-Dose Nevirapine Is Substantially Underestimated. J Infect Dis 2005, 192:16–23. This is an important article that documents that by using new assays to detect NVP resistance following its use in MTCT, we underestimate NVP resistance. This article is important as it may affect, hopefully, future MTCT policy in resource-poor settings.

    Article  PubMed  CAS  Google Scholar 

  25. Flys T, Nissley DV, Claasen CW, et al.: Sensitive Drug-Resistance Assays Reveal Long-Term Persistence of HIV-1 Variants with the K103N Nevirapine (NVP) Resistance Mutation in Some Women and Infants after the Administration of Single-Dose NVP: HIVNET 012. J Infect Dis 2005, 192:24–29.

    Article  PubMed  CAS  Google Scholar 

  26. Eshleman S, Hoover D, Chen S, et al.: Comparison of nevirapine (NVP) resistance in women with subtype C compared to subtypes A and D after single dose NVP [abstract 799]. Paper presented at the 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA, February 22–25, 2005.

  27. Sullivan J: South African Intrapartum Nevirapine Trial: selection of resistance mutations [abstract LbPeB9024]. Paper presented at the 14th International Conference on AIDS. Barcelona, Spain, July 7–12, 2002.

  28. Martinson N, Pumla L, Morris L, et al.: Effectiveness of Singledose Nevirapine in a Second Pregnancy [abstract 103]. Paper presented at the 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA, February 22–25, 2005.

  29. McIntyre J, Martinson N: Addition of short course combivir to single dose viramune for prevention of mother to child transmission of HIV-1 can significantly decrease the subsequent development of maternal NNRTI-resistant virus. Paper presented at the XV International AIDS Conference. Bangkok, Thailand, July 11–16, 2004.

  30. Palombi L, Germano P, Liotta G: HAART in Pregnancy: Safety, Effectiveness, and Protection from Viral Resistance: Results from the DREAM Cohort. Paper presented at the 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA, February 22–25, 2005.

  31. De CockKM, Fowler MG, Mercier E, et al.: Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000, 283:1175–1182.

    Article  PubMed  Google Scholar 

  32. Coutsoudis A, Dabis F, Fawzi W, et al.: Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis 2004, 189:2154–2166.

    Article  PubMed  Google Scholar 

  33. Wilkinson D, Floyd K, Gilks CF: Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity. AIDS 1998, 12:1675–1682.

    Article  PubMed  CAS  Google Scholar 

  34. Sweat MD, O’Reilly KR, Schmid GP, et al.: Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries. AIDS 2004, 18:1661–1671.

    Article  PubMed  CAS  Google Scholar 

  35. Sherman GG, Jones SA, Coovadia AH, et al.: PMTCT from research to reality—results from a routine service. S Afr Med J 2004, 94:289–292.

    PubMed  CAS  Google Scholar 

  36. Quaghebeur A, Mutunga L, Mwanyumba F, et al.: Low efficacy of nevirapine (HIVNET012) in preventing perinatal HIV-1 transmission in a real-life situation. AIDS 2004, 18:1854–1856.

    Article  PubMed  Google Scholar 

  37. Chersich M, Urban M, Gray G, et al.: Challenges encountered when administering nevirapine for the prevention of MTCT in pilot programs in South Africa. Paper presented at the Third Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Kampala, Uganda, September 9–13, 2001.

  38. Temmerman M, Quaghebeur A, Mwanyumba F, Mandaliya K: Mother-to-child HIV transmission in resource poor settings: how to improve coverage? AIDS 2003, 17:1239–1242.

    Article  PubMed  Google Scholar 

  39. The United Nations Children’s Fund, World Health Organization: Antenatal care in developing countries: promises, achievements and missed opportunities. Geneva, Switzerland: World Health Organization; 2003.

    Google Scholar 

  40. Cartoux M, Msellati P, Meda N, et al.: Attitude of pregnant women towards HIV testing in Abidjan, Cote d’Ivoire and Bobo-Dioulasso, Burkina Faso. DITRAME Study Group (ANRS 049 Clinical Trial). Diminution de la Transmission Mere Enfant du VIH. Agence Nationale de Recherches sur le SIDA. AIDS 1998, 12:2337–2344.

    Article  PubMed  CAS  Google Scholar 

  41. Sint TT, Dabis F, Kamenga C, et al.: Should nevirapine be used to prevent mother-to-child transmission of HIV among women of unknown serostatus? Bull World Health Organ 2005, 83:224–248.

    PubMed  Google Scholar 

  42. Stringer JS, Sinkala M, Stout JP, et al.: Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings. J Acquir Immune Defic Syndr 2003, 32:506–513.

    Article  PubMed  CAS  Google Scholar 

  43. Gray GE, Urban MF, Chersich MF, et al.:A randomized trial of two post-exposure prophylaxis regimens to reduce mother-to-child HIV transmission in infants of untreated mothers. AIDS 2005, In press.

  44. Taha TE, Kumwenda NI, Gibbons A, et al.: Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomized clinical trial. Lancet 2003, 362:1171–1177.

    Article  PubMed  Google Scholar 

  45. Bulterys M, Jamieson DJ, O’Sullivan MJ, et al.: Rapid HIV-1 testing during labor: a multicenter study. JAMA 2004, 292:219–223.

    Article  PubMed  CAS  Google Scholar 

  46. Chersich MF, Violari A, Jivkov B, et al.: Initiating early postpartum voluntary counseling and testing in a resourceconstrained setting. Paper presented at the 14th International Conference on AIDS. Barcelona, Spain, July 7–12, 2002.

  47. McIntyreJ: Mothers infected with HIV. Br Med Bull 2003, 67:127–135.

    Article  PubMed  Google Scholar 

  48. Newell ML, Coovadia H, Cortina-Borja M, et al.: Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004, 364:1236–1243.

    Article  PubMed  Google Scholar 

  49. Nakiyingi JS, Bracher M, Whitworth JA, et al.: Child survival in relation to mother’s HIV infection and survival: evidence from a Ugandan cohort study. AIDS 2003, 17:1827–1834.

    Article  PubMed  Google Scholar 

  50. Gray R, Li X, Serwadda D, et al.: Pregnancy and the Risk of Incident HIV in Rakai, Uganda, a Cause for Concern. Paper presented at the 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA, February 22–25, 2005.

  51. World Health Organization, United Nations Population Fund, The United Nations Children’s Fund, World Bank Group: Pregnancy, childbirth, postpartum and newborn care: a guide for essential practice. Geneva, Switzerland: World Health Organization; 2003.

    Google Scholar 

  52. Desgrees-du-Lou A, Msellati P, Viho I, et al.: Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIV-infected women. Int J STD AIDS 2002, 13:462–468.

    Article  PubMed  Google Scholar 

  53. Horizons, Population Council: Family planning and PMTCT: examining interrelationships, strengthening linkages. Washington, DC: Population Council; 2003.

    Google Scholar 

  54. Gray RH, Wawer MJ, Serwadda D, et al.: Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 1998, 351:98–103.

    Article  PubMed  CAS  Google Scholar 

  55. Hunter SC, Isingo R, Boerma JT, et al.: The association between HIV and fertility in a cohort study in rural Tanzania. J Biosoc Sci 2003, 35:189–199.

    Article  PubMed  Google Scholar 

  56. World Health Organization:Strategic approaches to the prevention of HIV infection in infants: report of a WHO meeting, Morges, Switzerland. Geneva, Switzerland: World Health Organization; 2003.

    Google Scholar 

  57. New data on the prevention of mother-to-child transmission of HIV and their policy implications.WHO Technical Consultation on Behalf of the UNFPA/UNICEF/WHO/UNAIDS Inter-Agency Task Team on Mother-to-Child Transmission of HIV, Geneva, Switzerland, 11–13 October 2000. Geneva, Switzerland: World Health Organization; 2001.

    Google Scholar 

  58. Marston B, De Cock KM: Multivitamins, nutrition, and antiretroviral therapy for HIV disease in Africa. N Engl J Med 2004, 351:78–80.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Perinatal HIV Research Unit, University of the Witwaterstrand, Chris Hani Baragwanath Hospital, Old Potch Road, PO Berstham, 2013, Soweto, South Africa

    Glenda E. Gray MBBCh, FCPaed(SA)

Authors
  1. Matthew F. Chersich MBBCh, MSC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Glenda E. Gray MBBCh, FCPaed(SA)
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chersich, M.F., Gray, G.E. Progress and emerging challenges in preventing mother-to-child transmission. Curr Infect Dis Rep 7, 393–400 (2005). https://doi.org/10.1007/s11908-005-0014-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-005-0014-0

Keywords

Search

Navigation